These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 7059982

  • 1. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ, Hill GJ.
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [Abstract] [Full Text] [Related]

  • 2. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomas.
    Hill HZ, Hill GJ, Miller CL, Pfaller M, Weiss K, Galin M.
    Cancer Res; 1979 Mar; 39(3):934-9. PubMed ID: 427782
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G, Giraldi T, Lassiani L, Nisi C.
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [Abstract] [Full Text] [Related]

  • 6. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy.
    Brereton HD, Bryant TL, Young RC.
    Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044
    [Abstract] [Full Text] [Related]

  • 7. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V, Dimov A, Georgieva N.
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC, Sidky YA, Hatcher JF, Bryan GT.
    Cancer Res; 1988 May 01; 48(9):2329-34. PubMed ID: 3356000
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
    Povlsen CO, Jacobsen GK.
    Cancer Res; 1975 Oct 01; 35(10):2790-6. PubMed ID: 1157050
    [Abstract] [Full Text] [Related]

  • 11. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
    Mitchell MS, Mokyr MB, Davis JM.
    J Clin Invest; 1977 Jun 01; 59(6):1017-26. PubMed ID: 863999
    [Abstract] [Full Text] [Related]

  • 12. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
    Schmid FA, Otter GM, Chen CF.
    Cancer Res; 1986 Sep 01; 46(9):4469-71. PubMed ID: 3731103
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapy of an experimental glioma with nitrosoureas.
    Tator CH, Day A, Ng R, Liberman L.
    Cancer Res; 1977 Feb 01; 37(2):476-81. PubMed ID: 832271
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU) in the Fischer 344 rat.
    Kramer RA, Boyd MR.
    J Pharmacol Exp Ther; 1983 Nov 01; 227(2):409-14. PubMed ID: 6631721
    [Abstract] [Full Text] [Related]

  • 17. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM.
    Cancer Treat Rep; 1976 Jun 01; 60(6):665-98. PubMed ID: 782694
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ, Moyer JD, Suffness M, Harrison SD, Cysyk R, Hamilton TC, Plowman J.
    Cancer Res; 1994 Feb 01; 54(3):724-9. PubMed ID: 8306334
    [Abstract] [Full Text] [Related]

  • 19. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ, Falkson G.
    Med Pediatr Oncol; 1975 Feb 01; 1(2):107-11. PubMed ID: 1228411
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy of L1210 leukemia using neuraminidase-modified plasma membranes combined with chemotherapy.
    Pincus JH, Jameson AK, Brandt AE.
    Cancer Res; 1981 Aug 01; 41(8):3082-6. PubMed ID: 7248965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.